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ABSTRACT 
 
Aim:Primary biliary cirrhosis (PBC) is characterized by antimitochondrial antibody (AMA) against 
the pyruvate dehydrogenase complex (PDC) and chronic nonsuppurative destructive cholangitis 
(CNSDC). Pyruvate oxidation to acetyl-CoA by PDC is a key step in the glycolytic system. 
Estrogen-related receptor-α (ERRα) is functionally activated by inducible coactivators such as 
peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and Bcl-3. Moreover, the 
PGC-1α/ERRα axis interrupts glycolytic metabolism through the upregulation of pyruvate 
dehydrogenase kinase, isozyme 4 (PDK4), which functionally inhibits PDC-E1α and stimulates fatty 
acid oxidation. In this study, we investigated the PGC-1α/ERRα axis to clarify PDC dysfunction in 
CNSDC of PBC. Methods:The expression of PGC-1α, Bcl-3, ERRα, PDK4, and PDC-E1α was 
examined by immunohistochemistry in liver sections from patients with PBC and controls. The 
expression of these molecules, the activity of mitochondrial dehydrogenase and PDC, and their 
alterations by starvation, a treatment used to induce PGC-1α expression, were examined in cultured 
human biliary epithelial cells (BECs). Results:The nuclear expression of PGC-1α, Bcl-3, and ERRα 
was exclusively observed in CNSDC of PBC. Moreover, the expression of PDK4 and PDC-E1α was 
enhanced in CNSDC of PBC. In cultured BECs, the amplification of Bcl-3 and PDK4 mRNAs by 
RT-PCR and mitochondrial dehydrogenase activity were markedly increased but PDC activity was 
decreased according to the upregulation of PGC-1α. Conclusion:In CNSDC of PBC, the activation 
of the ERRα/PGC-1α axis was exclusively observed, suggesting the interference of PDC-related 
glycolytic function and the induction of the fatty acid degradation system. The switching of the 
cellular energy system is possibly associated with the pathogenesis of CNSDC in PBC. 
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INTRODUCTION 
 
 Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease characterized by 
progressive inflammatory destruction and the disappearance of small intrahepatic bile ducts.1,2 The 
most important serological feature of PBC is the presence of antimitochondrial antibodies (AMAs), 
which are detected in more than 95% of the PBC patients.2 The mitochondrial components 
recognized by AMAs have been identified as distinct subunits of the mitochondrial 2-oxoacid 
dehydrogenase complexes (2-OADCs) consisting of the pyruvate dehydrogenase (PDH) complex 
(PDC), oxoglutaric dehydrogenase complex (OGDC), and branched-chain ketoacid dehydrogenase 
complex (BCKD). These complexes loosely adhere to the inner mitochondrial membrane and consist 
of multiple copies of the E1, E2, and E3 subunits. Moreover, the E1 subunit of PDC exists as 2 
forms (E1α and E1β). The dominant reactivity of AMA is against the dihydrolipoamide 
acetyltransferase component (E2) of PDC.3 PDH catalyzes the conversion of pyruvate to acetyl-CoA, 
and it is an important control point in glucose and pyruvate metabolism in glycolytic metabolism.  
 PBC primarily affects middle-aged women, and the interlobular bile ducts are selectively 
damaged.1,2 Although bile ducts have not been identified as a target organ of hormone regulation, 
several hormonal factors have been suggested to play important roles in the pathogenesis of PBC.4 
The estrogen-related receptor α (ERRα) is the constitutively active nuclear hormone receptor that 
inhibits estrogen receptor (ER)-dependent effects through competition with ERα.5 ERRα is 
associated with mitochondrial fatty acid oxidation (β-oxidation), which includes electron transport, 
oxidative phosphorylation, and mitochondrial biogenesis, and it plays critical roles in the regulation 
of cellular energy metabolism.6 Moreover, ERRα is functionally modulated by inducible coactivators 
such as the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and Bcl-3, a 
cytokine-stimulated transcriptional regulator that synergizes with PGC-1α to coactivate ERRα.7,8 
Therefore, the PGC-1α/ERRα axis induces fatty acid oxidation but simultaneously interrupts the 
glycolytic system through the upregulation of pyruvate dehydrogenase kinase, isozyme 4 (PDK4), 
which binds to the E2 inner lipoyl domain (corresponding to the minimal T-cell epitope) for its 
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catalytic function and functionally inhibits PDC-E1α by phosphorylation.9-12 
 Although PBC is characterized by the presence of AMA against major autoantigens such as 
PDC, cellular energy metabolism that involves PDH, such as the conversion of pyruvate to 
acetyl-CoA in the glycolytic system, has not been observed in the bile ducts of PBC. In this study, 
we investigated the PGC-1α/ERRα axis to clarify the association of cellular energy metabolism in 
the pathogenesis of cholangiopathy in PBC. 
 
MATERIALS and METHODS 
 
Patients and preparation of liver tissue 
All tissue specimens were collected from the hepatobiliary file of our department. A total of 69 
needle liver specimens were obtained from 26 patients with PBC (histological stage13 I/II/III, 
12/10/4; mean age, 57 years; male/female, 3/23) and controls, which included 16 patients with 
hepatitis C virus-related chronic hepatitis (CH-C), 5 patients with primary sclerosing cholangitis 
(PSC), and 22 patients with autoimmune hepatitis (AIH). The histopathological diagnoses were 
established by at least 2 pathologists who considered the clinical and laboratory data. All PBC 
patients were examined prior to ursodeoxycholic acid therapy, and AMA and/or M2 were detected in 
all PBC cases. All liver specimens consisted of neutral formalin-fixed paraffin-embedded tissues; 
4-μm-thick sections were prepared for routine histological examinations and immunohistochemistry. 
This study was approved by the Kanazawa University Ethics Committee.  
 
Immunohistochemistry  
 After deparaffinization, the sections were pretreated in Target Retrieval Solution (Dako 
Japan Co., Ltd., Tokyo, Japan) in a microwave oven or water bath at 95°C for 20 min to improve the 
antigenicity of the tissue prior to immunostaining.14,15 Following endogenous peroxidase blocking in 
methanolic hydrogen peroxide for 20 min and incubation in normal goat serum (diluted 1:10; Vector 
Laboratories, Inc., Burlingame, CA) for 20 min, the sections were incubated at 4°C overnight with 
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primary antibodies against PGC-1α (rabbit polyclonal, diluted 1:100, Bethyl Laboratories, Inc., 
Montgomery, TX), Bcl-3 (mouse monoclonal, clone 1E8, diluted 1:50, Abcam Japan, Tokyo, Japan), 
ERRα (mouse monoclonal, clone 1ERR87, 1 μg/mL, Santa Cruz Biotechnology, Inc., Santa Cruz, 
CA), PDK4 (mouse monoclonal, clone 1A10, 1 μg/mL, Abnova Corporation, Taipei City, Taiwan), 
and PDC-E1α (mouse monoclonal, clone 9H9AF5, 5 μg/mL, Abcam Japan). The CSA system (Dako 
Japan Co., Ltd.) was used for ERRα, and the Envision-HRP system (Dako Japan Co., Ltd.) was used 
for the others. After the benzidine reaction, the sections were weakly counterstained with 
hematoxylin. No positive staining was obtained when the primary antibodies were replaced with an 
isotype-matched, nonimmunized immunoglobulin, which was used as a negative control for the 
staining procedures.  
 
Histological examination 
 We primarily examined the interlobular bile ducts in these patients, including those with 
chronic nonsuppurative destructive cholangitis (CNSDC), in this study because they are selectively 
affected in PBC.1 For the PBC patients, in addition to evaluating their histological stages, the 
histological activity for chronic cholangitis was evaluated according to Nakanuma’s system.13 In 
brief, chronic cholangitis activity (CA) was categorized into 4 grades (CA0–3) according to the 
degree and distribution of chronic cholangitis. CA0 (no activity) was defined as absent or ambiguous 
bile duct damage. In CA1 (mild activity), 1 bile duct showed evident chronic cholangitis. In CA2 
(moderate activity), 2 or more bile ducts showed evident chronic cholangitis. In CA3 (marked 
activity), at least 1 damaged bile duct showed CNSDC and/or granulomatous cholangitis. For the 
semiquantitative evaluations of the immunohistochemistry, representative portal tracts that contained 
the interlobular bile ducts, including those with CNSDC, were chosen in each section for assessment. 
The immunoreactivity in the bile ducts was semiquantitatively graded as follows: negative (−), 
weakly positive (+), or strongly/enhanced positive (++).  
 
Cultured human biliary epithelial cells (BECs) and the induction of PGC-1α  
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 Two cultured human BEC lines were isolated from the explanted liver of 2 PBC patients. 
Informed consents to conduct research were obtained from both the patients. These cells were grown 
as monolayers in a standard medium containing 20% fetal calf serum (Life Technologies Japan, Ltd., 
Tokyo, Japan) in a 5% CO2-humidified incubator at 37°C.
16 The cell lines were confirmed to be 
biliary epithelial cells by the expression of the biliary-type cytokeratins CK7 and CK19 (>99%) and 
also aquaporin 1 (>90%). BECs were used between passages 6 and 10 for this study. To induce the 
expression of PGC-1α, the cultured BECs were treated by starvation (1% fetal calf serum),17,18 and 
the following examinations were performed. 
 
Assessment of cell viability and mitochondrial dehydrogenase activity 
Approximately 1 × 104 cells/well placed into 96-well plates were treated by starvation to 
induce PGC-1α. Cell counts and mitochondrial dehydrogenase activity were measured 24 h later 
with a microplate reader using the DNA-IdU Labeling and Detection Kit (Takara Bio Inc., Otsu, 
Japan) and the tetrazolium salt WST-1 assay (Roche Diagnostics GmbH, Penzberg, Germany) 
according to the manufacturer’s instructions. Mitochondrial dehydrogenase activity per cell was 
presented as a relative ratio of the optical density (OD) in WST-1/DNA-IdU labeling assays.  
 
Isolation of RNA and real-time reverse-transcription polymerase chain reaction (RT-PCR) 
 The basal levels of expression of ERRα, PGC-1α, Bcl-3, PDK4, and PDC-E1α mRNAs and 
their alterations by starvation were examined by RT-PCR and real-time PCR, respectively. Total 
RNA was extracted from cultured BECs using the RNeasy Total RNA System (QIAGEN GmbH, 
Hilden, Germany) according to the manufacturer’s instructions. Following this, 1 µg of total RNA 
was reverse transcribed with an oligo-(dT) primer and ReverTra Ace (Toyobo Co., Ltd., Osaka, 
Japan) to synthesize a cDNA template for PCR. For relative quantification, real-time quantitative 
PCR was performed according to a standard protocol using the Brilliant II SYBR Green QPCR 
Reagents and Mx300P QPCR System (Agilent Technologies, Tokyo, Japan), and the relative levels 
of gene expression were calculated using the comparative cycle threshold method. The specific 
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primers were as follows: PGC-1α: forward, 5′-TTGGTAACCGAACTGGTGCT-3′ and reverse, 
5′-GTGCAAAGTTCCCTCTCTGC-3′; Bcl-3: forward, 5′-CCCTATACCCCATGATGTGC-3′ and 
reverse, 5′-GGTGTCTGCCGTAGGTTGTT-3′; ERRα: forward, 
5′-TGGCTACCCTCTGTGACCTC-3′ and reverse, 5′-CTCATCCTGCAGTGGCAGT-3′; PDK4: 
forward, 5′-GGCCTAGTGTTGTGGTGCTT-3′ and reverse, 5′-GAGCTGGACTCCCACCATTA-3′; 
PDC-E1α: forward, 5′-GTCAGTGCTTCAAGCCAACA-3′ and reverse, 
5′-TTAAACTGCAGCCTGCCTTC-3′; and glyceraldehyde 3 phosphate dehydrogenase (GAPDH, 
internal positive control): forward, 5′-GGCCTCCAAGGAGTAAGACC-3′, and reverse, 
5′-AGGGGTCTACATGGCAACTG-3′. The results were obtained from 2 independent experiments 
and are presented as the relative levels of mRNA expression compared with the levels without any 
treatments. Negative controls were obtained by replacing the reverse transcriptase or cDNA samples 
with RNase- and DNase-free water. 
 
Quantitative and functional assessments of PDK4 expression and PDH activity 
 The levels of expression of PDK4 and PDH activity and the alterations in them resulting from 
the induction of PGC-1α by starvation in cultured BECs were measured using the PDK4 Human 
Enzyme-Linked Immunosorbent Assay (ELISA) Kit and the PDH Enzyme Activity Microplate 
Assay Kit, respectively, according to the manufacturer’s instructions.  
 
Statistical analysis   
 The data were analyzed using Mann–Whitney U test, paired t test, Wilcoxon signed-ranks test, 





Exclusive expression of PGC-1a, Bcl-3, and ERRa in the damaged bile ducts of PBC 
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 The expression of PGC-1α and ERRα was detected in the cytoplasm and nucleus of positive 
cells, and the nuclear expression indicated the activated forms. This was considered to be functional 
positivity. The expression of Bcl-3 was limited to the nucleus of positive cells. In the controls, strong 
nuclear expression of PGC-1α, Βcl-3, and ERRα was not detected in any interlobular bile ducts, 
including mildly injured bile ducts (hepatic bile duct injury) in CH-C and AIH. The bile ducts that 
exhibited almost normal or mild cholangitis also lacked these molecules in PBC; however, the 
damaged bile ducts that showed moderate to severe cholangitis, including CNSDC in PBC, 
preferentially expressed PGC-1α, Bcl-3, and ERRα in a nuclear pattern. As shown in Fig. 1, the 
nuclear expression of PGC-1α, Βcl-3, and ERRα in the bile ducts was exclusive in PBC, and the 
levels of expression of PGC-1α and Bcl-3 correlated well with the degree of CA activity in PBC. 
 
Expression of PDK4 and PDC-E1a in bile ducts 
 The expression of PDK4 was basically negative or weakly positive in the interlobular bile ducts, 
and bile ducts exhibiting strong positivity were not observed (Fig. 2). However, the frequency of 
weakly positive bile ducts was higher in PBC compared with that in controls (Fig. 2). In contrast, 
PDC-E1α was consistently expressed in all interlobular bile ducts (Fig. 2). Strong expression was 
more frequent in the bile ducts of PBC patients (Fig. 2). 
 
Effects of the induction of PGC-1α in cultured BECs on mitochondrial dehydrogenase activity 
 To investigate the alterations in mitochondrial dehydrogenase activity by the induction of 
PGC-1α in cultured BECs, we analyzed the relative cell counts and mitochondrial dehydrogenase 
activities in starved BECs using WST-1 and DNA-IdU labeling assays, respectively. As shown in Fig. 
3, the induction of PGC-1α by starvation downregulated the cell number; however, it did not affect 
the degree of total mitochondrial dehydrogenase activity. Therefore, the mitochondrial 
dehydrogenase activity per cell that was presented as the relative ratio of OD values was increased in 
the starved BECs by approximately 2-fold compared with that in nonstarved (static) BECs (Fig. 3).  
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Expression of Bcl-3, ERRa, PDK4, and PDC-E1a and their alterations by the induction of 
PGC-1α in cultured BECs  
 RT-PCR analysis revealed that the amplification of all mRNAs of PGC-1α, ERRα, PDK4, and 
PDC-E1α in cultured human BECs (Fig. 4A). Moreover, real-time PCR analysis demonstrated that 
the levels of amplification of mRNAs of PGC-1α, ERRα, and PDK4 were statistically increased 
according to the upregulation of PGC-1α by starvation, although the degrees of increase varied 
(paired t test or Wilcoxon signed-ranks test) (Fig. 4B). 
 
Assessment of PDK4 expression and PDH activity 
 PDK4 ELISA demonstrated that the levels of expression of PDK4 were significantly 
upregulated by the induction of PGC-1α by starvation in cultured BECs. In contrast, PDH enzyme 




 In contrast to ER, ERRα and its related family members, ERRβ and ERRγ, do not have known 
ligands; therefore, they are called orphan nuclear receptors. ERRα plays key roles in the gene 
regulatory control of the mitochondrial energetic systems. ERRα has been identified as a novel 
PGC-1α-binding partner, and the ERR family members must interact with PGC-1 coactivators to be 
transcriptionally active.19 Bcl-3 synergizes with PGC-1α to coactivate ERRα, and the complex of 
ERRα, PGC-1α, and Bcl-3 is found on an ERRα-responsive element within the PDK4 gene 
promoter.8 In mitochondrial energy systems, ERRα regulates fatty acid degradation (β-oxidation), 
which is an aerobic and more effective energy metabolic system compared with the anaerobic 
glycolytic system. Therefore, the PGC-1α/ERRα axis plays a key role in various aspects of cellular 
energy homeostasis, including mitochondrial biogenesis, thermal regulation, and glucose 
metabolism.10,20 Consistent with this function, ERRα is prominently expressed in tissues that have a 
high capacity for the β-oxidation of fatty acids, such as the heart, brown fat, and skeletal muscle.21 In 
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the liver, ERRα and PGC-1α are expressed at low levels; however, they are induced in fasting 
animals.18 Although these metabolic studies have been conducted in liver hepatocytes,18,22 there have 
been no reports regarding the metabolic state of BECs and the dysregulations of BECs in human 
biliary diseases, including PBC. The present study revealed that the activated expression of ERRα, 
PGC-1α, and Bcl-3 in a nuclear pattern was exclusively observed in the CNSDC of PBC. Although 
bile ducts that are similarly damaged from hepatic bile duct injury or hepatitis-associated bile duct 
injury have been observed in AIH and CH-C, no or weak ERRα expression in the nuclei was 
observed in these damaged bile ducts. However, the expression of PGC-1α and Bcl-3 correlated well 
with the degree of chronic CA in PBC, indicating that the cooperative expression of the 
ERRα/PGC-1α axis was closely associated with the energy metabolic responses in the pathogenesis 
of CNSDC in PBC. 
 The PDC-E1 enzyme is a heterotetramer of 2 α and 2 β subunits. The E1α subunit, which 
contains the E1 active site, plays a key role in the function of PDC. PDK decreases PDH activity 
through the phosphorylation of PDC-E1α. Three serine phosphorylation sites on PDC-E1α are 
targeted by PDKs, and the phosphorylation of PDC-E1α completely inhibits the activity of PDH.23 
There is increased phosphorylation of PDC in the heart and skeletal muscle in cases of starvation and 
diabetes, and this allows pyruvate to be conserved while mitochondrial fatty acid oxidation is 
increased.24 Four PDK isoenzymes (PDK1, -2, -3, and -4) have been identified. The expression of 
PDK4 is suppressed under basal conditions in most tissues; however, its expression is increased by 
starvation, glucocorticoids, diabetes, a high-fat diet, and extended exercise through the 
PGC-1α/ERRα axis, particularly in the heart, skeletal and other muscle tissues, kidney, and liver. 
PDK4 overexpression prevents glucose oxidation.10,24,25 The present study revealed the expression of 
PDK4 and its increases according to the induction of PGC-1α by starvation in cultured human BECs. 
Moreover, functional analysis confirmed the decrease in PDH function. These findings suggested 
that the functions of PDH in human BECs are regulated by the ERRα/PGC-1α axis and that in 
CNSDC, the exclusive expression of the PGC-1α/ERRα axis and the enhanced expression of PDK4 
result in PDH dysfunction through PDK4.  
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 Although samples with CNSDC have reactive findings such as enlargement compared with the 
original size of the bile duct and increased mitochondria,1,26,27 these damaged bile ducts finally 
undergo disappearance (bile duct loss),28 mainly through biliary apoptosis. This unique finding 
concerning the histogenesis of CNSDC in PBC can be explained by metabolic alterations. In other 
words, switching from the utilization of glucose to that of fatty acids as an energy source results in a 
more effective energy system, indicating that metabolic switching by ERRα/PGC-1α increases the 
metabolic activity of CNSDC in PBC. The in vitro study of cultured BECs demonstrated that the 
induction of PGC-1α by starvation caused an increase in mitochondrial dehydrogenase activity per 
cell. Although the oxidative phosphorylation of fatty acids is a vital part of metabolism, it produces 
reactive oxygen species such as superoxides and hydrogen peroxide, which lead to the propagation 
of free radicals and result in damaged and apoptotic cells and contribute to several diseases. In fact, 
several reports have already demonstrated that increased oxidative stress and enhanced biliary 
apoptosis are observed in the bile ducts of PBC patients.28-31 Therefore, metabolic switching from 
glycolytic systems to fatty acid oxidation has been speculated to cause an increased susceptibility to 
the apoptotic induction of CNSDC in PBC through oxidative stress.   
 ERRs share homology with ERs; however, ERRs do not bind to estrogen or other known 
physiological ligands. Therefore, ERRs inhibit ER-dependent estrogen effects through competition 
with ERα. ERs form homo or heterodimers that consist of ERα and ERβ, which bind to an 
estrogen-response element (ERE) and affect cell proliferation and the promotion of apoptosis and 
differentiation, respectively.32 Both ERα and ERβ are observed in bile ducts in the early stages of 
PBC; however, the disappearance of ERα in bile ducts during the cirrhotic stage and an estrogenic 
deficiency have been speculated to accompany the evolution of PBC toward ductopenia.4 In addition 
to this loss of ERα, the present study revealed that the activated expression of ERRα in a nuclear 
pattern was exclusively found in CNSDC of PBC, indicating that the activation of ERRα inhibits the 
cell-proliferating function of ERα and induces the bile duct loss caused by regenerative failure in 
CNSDC of PBC.  
 In conclusion, we demonstrated the activation of the ERRα/PGC-1α axis and the upregulation 
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of PDK4 in CNSDC of PBC, suggesting an interference in PDH function and the switching from 
glycolytic to fatty acid oxidation. Moreover, the dysfunction of PDH which are major epitopes for 
AMA suggests any associations with the pathogenesis of AMA. Further studies are required to 
clarify the etiology and mechanisms underlying the activation of the ERRα/PGC-1α axis in vivo and 
the production mechanism of AMA. Although compensatory responses to some bile duct injuries 
have been suggested, metabolic switching was possibly associated with the pathogenesis of CNSDC 
and the consequent bile duct loss in PBC. The enzymes conducting the correction of the metabolic 
system in BECs may also be the target of drugs in PBC. 
 
Competing Interest: None declared. 
 
Take home messages 
- In CNSDC of PBC, the activation of the ERRα/PGC-1α axis is exclusively observed. 
- The interference of PDC-related glycolytic function and the induction of the fatty acid degradation 
system are speculated in CNSDC of PBC.  
- The switching of the cellular energy system is possibly associated with the pathogenesis of CNSDC 
in PBC. 
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Figure legends 
 
Fig. 1  The expression of PGC-1α, Bcl-3, and ERRα in liver tissue and its correlation with chronic 
cholangitis activity (CA). A: Immunohistochemistry for PGC-1α, Bcl-3, and ERRα. Biliary 
epithelial cells with CNSDC of PBC expressed PGC-1α and ERRα strongly in the nucleus 
and weakly in the cytoplasm and expressed Bcl-3 in the nucleus (arrows). However, 
undamaged (almost normal) bile ducts with PBC and bile ducts with hepatitis C virus-related 
chronic hepatitis (CH-C) were negative for these molecules (arrowheads). B: There was good 
correlation between the expression of PGC-1α and Bcl-3 compared with the degree of chronic 
cholangitis (CA) in PBC. PGC-1α; r=0.69, p-value=0.001, Z value=3.20, Z (0.975)=1.95. 
Bcl-3; r=0.66, p-value=0.0009, Z value =3.11, Z (0.975)=1.95. C: Semiquantitative analyses 
revealed that the expression of these molecules in bile ducts was higher in PBC than that in 
controls. PGC-1α, p-value=0.002; Bcl-3, p-value < 0.001; ERRα, p-value < 0.001. Moreover, 
the statistical analysis excluding positive reactive cases (+) also revealed that the ratio of 
strong positive cases (++) were significantly higher in PBC than those in controls. PGC-1α, 
p-value = 0.004; Bcl-3, p-value < 0.001; ERRα, p-value < 0.001. 
 
Fig. 2  The expression of PDK4 and PDC-E1α in liver tissue. A: Tissue from patients with CNSDC 
in PBC weakly expresses PDK4 and strongly expresses PDC-E1α in cytoplasmic patterns. B: 
Semiquantitative analyses revealed that the expression of PDK4 was negative or weakly 
positive in the interlobular bile ducts, and the frequency of weakly positive bile ducts was 
higher in PBC patients than that in controls. PDC-E1α was basically expressed (weakly or 
strongly positive) in the interlobular bile ducts, and the frequency of strongly positive bile 
ducts was higher in PBC patients than that in controls. PDK4, p-value=0.008; PDC-E1α, 
p-value=0.015. 
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Fig. 3  Mitochondrial dehydrogenase activity in cultured BECs. The number of cells that were 
starved was decreased; however, the degree of mitochondrial dehydrogenase activity 
remained significantly unchanged in total. Mitochondrial dehydrogenase activity per cell, 
which is presented as the relative ratio of optical density (OD), was significantly higher in 
starved BECs by 0.69 ± 0.10-fold (mean ± S.E.M) than that in untreated (static) BECs (0.32 ± 
0.04-fold). p-value = 0.013.  Bars indicate mean and S.E.M. In the induction of PGC-1α 
expression by the starvation of cultured BECs, cell counts and mitochondrial dehydrogenase 
activity were measured with WST-1 and DNA-IdU labeling assays, respectively. The results 
were obtained from 2 independent experiments with 2 cell lines of cultured BECs.  
 
Fig. 4  The expression of Bcl-3, ERRα, PDK4, and PDC-E1α and PDH activity in cultured BECs. 
A: RT-PCR was performed for 40 cycles, and amplification of ERRα, PGC-1α, Bcl-3, PDK4, 
and PDC-E1α was detected as a single band from cultured BECs at the expected sizes. 
Negative controls (NCs) were obtained by replacing the reverse transcriptase with RNase- and 
DNase-free water for the reverse transcription. B: Real-time PCR analyses demonstrated that 
the fold-increase of ERRα, PGC-1α, Bcl-3, PDK4, and PDC-E1α by starvation were 1.7 ± 
0.2- (mean ± S.E.M, p-value = 0.048), 16.3 ± 1.8- (p-value = 0.003), 3.5 ± 1.3- (p-value = 
0.19), 4.6 ± 0.4- (p-value = 0.004), and 1.3 ± 0.1 (p-value = 0.030)-fold, respectively. C: An 
enzyme-linked immunosorbent assay for PDK4 demonstrated that the expression of PDK4 
was significantly upregulated by 2.5 ± 0.2-fold by the induction of PGC-1α (starved state) in 
cultured BECs (p-value = 0.01). In contrast, PDH enzyme activity was decreased by 0.4 ± 
0.01-fold in the starved state (p-value < 0.001). The results were obtained from 2 independent 
experiments with 2 cell lines and are shown as the relative levels of expression compared with 
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